Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kos and Takeda to copromote Niaspan and Advicor in U.S.

Nov. 6, 2003

BMP2 gene and variants linked to osteoporosis

Nov. 6, 2003

Approval received for Sucanon in Mexico

Nov. 5, 2003

Study of transplanted replacement islets without long-term immune suppression

Nov. 5, 2003

Relationship between fracture risk reduction and improvement in BMD

Nov. 5, 2003

Teriparatide reported to induce long-term back pain relief in osteoporosis

Nov. 4, 2003

Indian researchers report a potential antidiabetic agent from plant extracts

Nov. 4, 2003

Novel NPY antagonists prepared and tested at Banyu

Nov. 3, 2003

New nitrooxy-containing probucol analogues recently patented by NicOx

Nov. 3, 2003

Two series of GSK-3 inhibitors claimed in recent patent

Oct. 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...